# Dronedarone

## Multaq 400mg

| 藥物代碼 | OMUL |
| :--- | :--- |
| 適應症 | Paroxysmal or persistent atrial fibrillation: To reduce the risk of hospitalization for atrial fibrillation \(AF\) in patients in sinus rhythm with a history of paroxysmal or persistent AF |
| 副作用 | &gt;10%:Cardiovascular: Prolonged Q-T interval on ECG \(Bazett; 28% \[placebo: 19%\]; defined as &gt;450 msec in males or &gt;470 msec in female\); Renal: Increased serum creatinine \(51%; increased &gt;10%; occurred 5 days after initiation\)1% to 10%:Cardiovascular: Bradycardia \(3%\); Dermatologic: Allergic dermatitis \(&lt;=5%\), dermatitis \(&lt;=5%\), eczema \(&lt;=5%\), pruritus \(&lt;=5%\), skin rash \(&lt;=5%; described as generalized, macular, maculopapular, erythematous\); Gastrointestinal: Diarrhea \(9%\), nausea \(5%\), abdominal pain \(4%\), dyspepsia \(2%\), vomiting \(2%\); Neuromuscular & skeletal: Weakness \(7%\)&lt;1%, postmarketing, and/or case reports: Acute hepatic failure \(requiring transplant\), anaphylaxis, angioedema, atrial flutter \(with 1:1 atrioventricular conduction\), cardiac failure \(new or worsened\), dysgeusia, hepatic injury, hyperbilirubinemia, hypersensitivity angiitis, increased blood urea nitrogen, increased liver enzymes, interstitial pulmonary disease, pneumonitis, pulmonary fibrosis, skin photosensitivity, vasculitis |
| 禁忌 | Hypersensitivity to dronedarone or any component of the formulation; permanent atrial fibrillation \(patients in whom normal sinus rhythm will not or cannot be restored\); symptomatic heart failure \(heart failure with recent \[within the last 4 weeks\] decompensation requiring hospitalization or NYHA Class III or IV symptoms\); liver or lung toxicity related to previous amiodarone use; second-degree or third-degree atrioventricular block or sick sinus syndrome \(except when used in conjunction with a functioning artificial pacemaker\); bradycardia 280 msec; severe hepatic impairment; pregnancy; breastfeeding |
| 藥物保存方式 | 30°C 以下儲存 |
| 用法用量 | 400 mg twice daily with meals |
| 肝功能異常 | 需 調 整 劑 量  Severe impairment: Use is contraindicated. |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 不可使用 |
| 孕期用藥建議 | Human \(and animal\) data suggest risk |
| 附帶說明 | \[仿單\] 禁忌 |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity 無\(很少\)資料 - 避免使用 |
| 附帶說明 | \[仿單\] 禁忌 |
| 注射劑給藥建議途徑 | WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

